TMEM201 and inflammatory bowel disease: In a murine model of intestinal inflammation using SAMP1/Yit mice, which is considered to be similar to inflammatory bowel disease in humans, treatment with sgp130Fc improved inflammation, as validated by less destruction of the epithelial layer and by less inflammatory infiltrates in the lamina propria of the small intestine [120].